Differential expression and pharmacology of native p2× receptors in rat and primate sensory neurons

Journal of Neuroscience

Volumn 32, Issue 34, 2012, Pages 11890-11896

  Serrano, Alexandre ^a   Mo, Gary ^a,b   Grant, Rebecca ^a   Paré, Michel ^a   O'Donnell, Dajan ^a   Yu, Xiao Hong ^a   Tomaszewski, Miroslaw J ^a   Perkins, Martin N ^a   Séguéla, Philippe ^b   Cao, Chang Qing ^a  

^a ASTRAZENECA   (United Kingdom)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X3 RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MACACA FASCICULARIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSORY NERVE CELL; SPECIES DIFFERENCE; SPINAL GANGLION;

ADENOSINE TRIPHOSPHATE; ADULT; ANALYSIS OF VARIANCE; ANIMALS; CELL COUNT; CELLS, CULTURED; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; FEMALE; GANGLIA, SPINAL; GENE EXPRESSION; HUMANS; MACACA FASCICULARIS; MALE; MEMBRANE POTENTIALS; MIDDLE AGED; MUTAGENESIS; PATCH-CLAMP TECHNIQUES; PURINERGIC P2X RECEPTOR AGONISTS; PURINERGIC P2X RECEPTOR ANTAGONISTS; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2X; SENSORY RECEPTOR CELLS; SPECIES SPECIFICITY; TRANSFECTION; YOUNG ADULT;

EID: 84865239741     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0698-12.2012     Document Type: Article

References (27)

1. Barclay J, Patel S, Dorn G, Wotherspoon G, Moffatt S, Eunson L, Abdel'al S, Natt F, Hall J, Winter J, Bevan S, Wishart W, Fox A, Ganju P (2002) Functional downregulation of P2X3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain. J Neurosci 22:8139-8147.
2. Bodnar M, Wang H, Riedel T, Hintze S, Kato E, Fallah G, Gröger-Arndt H, Giniatullin R, Grohmann M, Hausmann R, Schmalzing G, Illes P, Rubini P (2011) Amino acid residues constituting the agonist binding site of the human P2X3 receptor. J Biol Chem 286:2739-2749.
3. Carter DS, Alam M, Cai H, Dillon MP, Ford AP, Gever JR, Jahangir A, Lin C, Moore AG, Wagner PJ, Zhai Y (2009) Identification and SAR of novel diaminopyrimidines. Part 1: the discovery of RO-4, a dual P2X(3)/ P2X(2/3) antagonist for the treatment of pain. Bioorg Med Chem Lett 19:1628 -1631.
4. Chen Y, Li GW, Wang C, Gu Y, Huang LY (2005) Mechanisms underlying enhanced P2X receptor-mediated responses in the neuropathic pain state. Pain 119:38-48.
5. Cockayne DA, Dunn PM, Zhong Y, Rong W, Hamilton SG, Knight GE, Ruan HZ, Ma B, Yip P, Nunn P, McMahon SB, Burnstock G, Ford AP (2005) P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP. J Physiol 567:621- 639.
6. Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain G, Berson A, Kassotakis L, Hedley L, Lachnit WG, Burnstock G, McMahon SB, Ford AP (2000) Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407:1011-1015.
7. Collo G, North RA, Kawashima E, Merlo-Pich E, Neidhart S, Surprenant A, Buell G (1996) Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci 16:2495-2507.
8. Cox KH, DeLeon DV, Angerer LM, Angerer RC (1984) Detection of mrnas in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Biol 101:485-502.
9. Ford AP (2012) In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization. Purinergic Signal 8:3-26.
10. Gever JR, Cockayne DA, Dillon MP, Burnstock G, Ford AP (2006) Pharmacology of P2X channels. Pflugers Arch 452:513-537.
11. Jahangir A, Alam M, Carter DS, Dillon MP, Bois DJ, Ford AP, Gever JR, Lin C, Wagner PJ, Zhai Y, Zira J (2009) Identification and SAR of novel diaminopyrimidines. Part 2: the discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of pain. Bioorg Med Chem Lett 19:1632-1635.
12. Jarvis MF, Wismer CT, Schweitzer E, Yu H, van Biesen T, Lynch KJ, Burgard EC, Kowaluk EA (2001) Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X(3) allosteric modulator, cibacron blue. Br J Pharmacol 132:259-269.
13. Kaan TK, Yip PK, Patel S, Davies M, Marchand F, Cockayne DA, Nunn PA, Dickenson AH, Ford AP, Zhong Y, Malcangio M, McMahon SB (2010) Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats. Brain 133:2549-2564.
14. Kawate T, Michel JC, Birdsong WT, Gouaux E (2009) Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature 460:592-598.
15. Kobayashi K, Fukuoka T, Yamanaka H, Dai Y, Obata K, Tokunaga A, Noguchi K (2005) Differential expression patterns of mRNAs for P2X receptor subunits in neurochemically characterized dorsal root ganglion neurons in the rat. J Comp Neurol 481:377-390.
16. Lewis C, Neidhart S, Holy C, North RA, Buell G, Surprenant A (1995) Coexpression of P2X2 and P2X3 receptor subunits can account for ATPgated currents in sensory neurons. Nature 377:432-435.
17. Matsuka Y, Ono T, Iwase H, Mitrirattanakul S, Omoto KS, Cho T, Lam YY, Snyder B, Spigelman I (2008) Altered ATP release and metabolism in dorsal root ganglia of neuropathic rats. Mol Pain 4:66.
18. McGaraughty S, Wismer CT, Zhu CZ, Mikusa J, Honore P, Chu KL, Lee CH, Faltynek CR, Jarvis MF (2003) Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration. Br J Pharmacol 140:1381-1388.
19. Mennicken F, Zhang J, Hoffert C, Ahmad S, Beaudet A, O'Donnell D (2003) Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia. J Comp Neurol 465:349-360.
20. Mo G, Grant R, O'Donnell D, Ragsdale DS, Cao CQ, Séguéla P (2011) Neuropathic Nav1.3-mediated sensitization to P2X activation is regulated by protein kinase C. Mol Pain 7:14.
21. Mogil JS, Davis KD, Derbyshire SW (2010) The necessity of animal models in pain research. Pain 151:12-17.
22. Pankratov YuV, Lalo UV, Dashkin AN, Krishtal A (2001) Heterogeneity of the functional expression of P2X3 and P2X2/3 receptors in the primary nociceptive neurons of rat. Neurochem Res 26:993-1000.
23. Sokolova E, Skorinkin A, Moiseev I, Agrachev A, Nistri A, Giniatullin R (2006) Experimental and modeling studies of desensitization of P2X3 receptors. Mol Pharmacol 70:373-382.
24. Tsuzuki K, Kondo E, Fukuoka T, Yi D, Tsujino H, Sakagami M, Noguchi K (2001) Differential regulation of P2X(3)mRNAexpression by peripheral nerve injury in intact and injured neurons in the rat sensory ganglia. Pain 91:351-360.
25. Vulchanova L, Riedl MS, Shuster SJ, Buell G, Surprenant A, North RA, Elde R (1997) Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals. Neuropharmacology 36:1229-1242.
26. Xiang Z, Bo X, Burnstock G (1998) Localization of ATP-gated P2X receptor immunoreactivity in rat sensory and sympathetic ganglia. Neurosci Lett 256:105-108.
27. Yiangou Y, Facer P, Birch R, Sangameswaran L, Eglen R, Anand P (2000) P2X3 receptor in injured human sensory neurons. Neuroreport 11: 993-996.